Injectable formulation of a novel anti-breast cancer drug.
Acetyltanshinone IIA (ATA), a novel discovered anti-breast drug, is chemically modified from Tanshinone IIA with low aqueous solubility and bioavailability which is isolated from the dry root of the Chinese herbal Danshen. After specific chemical conformational modifications, ATA has many advantages...
Saved in:
Main Author: | Wei, Na. |
---|---|
Other Authors: | School of Chemical and Biomedical Engineering |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/50528 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation of biocompatible polymeric nanoparticles as therapeutic carriers in inhaled drug delivery : effects of different formulation parameters.
by: Shi, Fiona Xuehui.
Published: (2009) -
Formulation of particles for pulmonary drug delivery
by: Meer Saiful Hassan
Published: (2010) -
LC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cells
by: Bahareh Haji Rasouliha
Published: (2011) -
Diagnosis of breast cancer using skin surface electropotentials
by: Hee, Lily Li Li.
Published: (2010) -
Effect of addition of magnesium stearate on pollen shape hydroxyapatite drug carrier in dry powder inhaler formulations
by: Tan, Winnie Cai Ying.
Published: (2010)